BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35319525)

  • 1. Thymic Mucoepidermoid Carcinoma: A Clinicopathologic and Molecular Study.
    Murase T; Nakano S; Sakane T; Domen H; Chiyo M; Nagasaka S; Tanaka M; Kawahara Y; Toishi M; Tanaka T; Nakamura S; Sawabata N; Okami J; Mukaida H; Tzankov A; Szolkowska M; Porubsky S; Marx A; Roden AC; Inagaki H
    Am J Surg Pathol; 2022 Aug; 46(8):1160-1169. PubMed ID: 35319525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
    Nakano S; Okumura Y; Murase T; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Kawakita D; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
    Histopathology; 2022 Mar; 80(4):729-735. PubMed ID: 34657306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
    Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
    Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.
    Nakayama T; Miyabe S; Okabe M; Sakuma H; Ijichi K; Hasegawa Y; Nagatsuka H; Shimozato K; Inagaki H
    Mod Pathol; 2009 Dec; 22(12):1575-81. PubMed ID: 19749740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma.
    Saade RE; Bell D; Garcia J; Roberts D; Weber R
    JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):234-40. PubMed ID: 26796488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.
    Okumura Y; Nakano S; Murase T; Ueda K; Kawakita D; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
    Cancer Sci; 2020 Nov; 111(11):4195-4204. PubMed ID: 32860299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping.
    Fehr A; Werenicz S; Trocchi P; Falk M; Friedrich RE; Stammler A; Stang A; Oesterling F; Khil L; Stenman G; Böcker W; Tiemann K; Löning T
    Virchows Arch; 2021 Nov; 479(5):975-985. PubMed ID: 34231055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
    Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
    Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.
    Okumura Y; Miyabe S; Nakayama T; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
    Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.
    Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL
    Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis.
    Cipriani NA; Lusardi JJ; McElherne J; Pearson AT; Olivas AD; Fitzpatrick C; Lingen MW; Blair EA
    Am J Surg Pathol; 2019 Jul; 43(7):885-897. PubMed ID: 31021855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion.
    Lennerz JK; Perry A; Mills JC; Huettner PC; Pfeifer JD
    Am J Surg Pathol; 2009 Jun; 33(6):835-43. PubMed ID: 19092631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
    Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study.
    Shinomiya H; Ito Y; Kubo M; Yonezawa K; Otsuki N; Iwae S; Inagaki H; Nibu KI
    Hum Pathol; 2016 Nov; 57():37-44. PubMed ID: 27393417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of MAML2 gene split in mucoepidermoid carcinoma.
    Noda H; Okumura Y; Nakayama T; Miyabe S; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
    Cancer Sci; 2013 Jan; 104(1):85-92. PubMed ID: 23035786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions.
    Anzick SL; Chen WD; Park Y; Meltzer P; Bell D; El-Naggar AK; Kaye FJ
    Genes Chromosomes Cancer; 2010 Jan; 49(1):59-69. PubMed ID: 19827123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells.
    Chen Z; Lin S; Li JL; Ni W; Guo R; Lu J; Kaye FJ; Wu L
    Oncogene; 2018 Apr; 37(14):1885-1895. PubMed ID: 29353885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
    Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.
    Birkeland AC; Foltin SK; Michmerhuizen NL; Hoesli RC; Rosko AJ; Byrd S; Yanik M; Nor JE; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
    Oral Oncol; 2017 May; 68():5-8. PubMed ID: 28438292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic Mucoepidermoid Carcinoma: Report of a Case With CTRC1/3-MALM2 Molecular Studies.
    Prieto-Granada CN; Inagaki H; Mueller J
    Int J Surg Pathol; 2015 Jun; 23(4):277-83. PubMed ID: 25782731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.